newsfilter
← Latest News
GlobeNewswire·

Pasithea Therapeutics Announces Exhibit at Children's Tumor Foundation 2026 NF Conference

-- Company will engage with NF1 community following recent FDA Fast Track and Rare Pediatric Disease Designations for lead NF1 treatment candidate PAS-004 – – Participants interested in meeting with Pasithea are